Microbot Medical
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-6.09
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.52

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.76-1.36-9.02-4.39-0.68-5.90-5.30-4.730.20-1.550.11-0.68
Price/Sales ratio
57.22425.90N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
9.86-149.1951.403.343.771.372.013.702.993.711.821.37
Price/Cash Flow ratio
-2.11-1.62-110.92-6.86-0.94-6.72-6.76-5.69-1.89-1.96-0.91-0.94
Price/Free Cash Flow ratio
-2.04-1.57-107.50-6.78-0.90-6.50-6.67-5.65-1.87-1.95-0.90-0.90
Price/Earnings Growth ratio
0.130.030.090.060.020.190.21-0.21-0.000.01-0.000.19
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%85.47%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-3054.34%-31384.61%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-3187.84%-31123.07%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-3235.27%-31123.93%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-1.48%2.49%-0.28%-30.59%200.05%-1.42%-0.87%0.38%896.11%N/AN/A-1.42%
Return on Assets
-100.96%-171.61%-286.90%-68.86%-118.88%-19.79%-35.19%-67.20%1099.21%-128.97%1203.81%-118.88%
Return On Equity
-557.67%10902.69%-569.75%-76.16%-547.65%-23.30%-38.04%-78.36%1438.22%-238.61%1878.12%-547.65%
Return on Capital Employed
-147.68%-322.41%-372.72%-50.20%544.66%-22.41%-36.45%-76.82%-177.83%-217.02%-89.04%-22.41%
Liquidity Ratios
Current Ratio
2.301.544.2320.701.227.4418.77N/AN/AN/A4.261.22
Quick Ratio
2.341.304.2320.561.227.9818.778.094.302.093.961.22
Cash ratio
2.171.233.4520.421.105.9614.606.801.180.651.181.10
Days of Sales Outstanding
149.9090.47N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A50.87KN/A1.26KN/A-11.39K-26.83-835.65-368.57N/AN/AN/A
Operating Cycle
N/A50.96KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A536.767.33K1.35K4.25K1.23K1.47K1.33K415.091.22KN/A1.23K
Cash Conversion Cycle
N/A50.43KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
145.460.010.02N/AN/AN/A0.00N/AN/AN/A0.23N/A
Debt Equity Ratio
803.42-1.190.04N/AN/AN/A0.00N/AN/AN/A0.30N/A
Long-term Debt to Capitalization
0.634.920.04N/AN/AN/AN/AN/AN/AN/A0.05N/A
Total Debt to Capitalization
0.996.140.04N/AN/AN/A0.00N/AN/AN/AN/AN/A
Interest Coverage Ratio
-23.86-71.74-28.84-22.13N/A-70.29-0.11N/AN/AN/A950N/A
Cash Flow to Debt Ratio
-0.00-76.89-10.34N/AN/AN/A-38.78N/AN/AN/AN/AN/A
Company Equity Multiplier
5.52-63.521.981.104.601.171.081.161.301.851.301.30
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-27.02-262.21N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.031.031.011.041.031.011.001.001.001.001.03
Cash Flow Coverage Ratio
-0.00-76.89-10.34N/AN/AN/A-38.78N/AN/AN/AN/AN/A
Short Term Coverage Ratio
-0.001.53KN/AN/AN/AN/A-38.78N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A